Metomidate

This classification denotes a sedative and hypnotic with the molecular formula C13H14N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Z18ZYL8Y51, chemically known as 1h-imidazole-5-carboxylic acid, 1- (1-phenylethyl)-, methyl ester, monohydrochloride but generally known as metomidate, which bears US NIH Compound Identifier 21474. European Medicines Agency schedules Metomidate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08907MIG. The term METOMIDATE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 21 No. 12 1967, List 7). METOMIDATE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule metomidate under HS 29332990 and SITC 51573. As of Q4 2014, METOMIDATE remains the US FDA Preferred Term for this commodity. Metomidate bears US NLM identifiers UMLS ID C0025856 and NCI Concept Code C90941. SMILES: O(C(=O)C1N(C(C2CCCCC2)C)CNC1)C.